|
Volumn 345, Issue 3, 2001, Pages 211-214
|
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ILLICIT DRUG;
INTERFERON;
RIBAVIRIN;
AFFECTIVE NEUROSIS;
DEPRESSION;
DISEASE TRANSMISSION;
DRUG WITHDRAWAL;
HEALTH CARE POLICY;
HEMOLYTIC ANEMIA;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
INTRAVENOUS DRUG ABUSE;
PREVALENCE;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
TREATMENT PLANNING;
UNITED STATES;
CLINICAL APPROACH/SOURCE;
HEALTH CARE AND PUBLIC HEALTH;
PROFESSIONAL PATIENT RELATIONSHIP;
ANTIVIRAL AGENTS;
ETHICS, MEDICAL;
HEALTH POLICY;
HEPATITIS C;
HUMANS;
INTERFERONS;
MEDICAL FUTILITY;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PRACTICE GUIDELINES;
PREJUDICE;
RECURRENCE;
RISK;
SUBSTANCE ABUSE, INTRAVENOUS;
SUBSTANCE-RELATED DISORDERS;
UNITED STATES;
WITHHOLDING TREATMENT;
|
EID: 0035913261
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200107193450311 Document Type: Review |
Times cited : (210)
|
References (50)
|